Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention
Completed · Phase 4
Conditions studied: Migraine, Episodic Migraine, Phonophobia, Photophobia
In brief
The purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic migraine.
Key facts
- Study ID
- NCT05207865
- Run by
- Pfizer
- People needed
- 441
- Starts
- 2022-03-15
- Expected to finish
- 2024-07-02
- Last updated by the study team
- 2025-09-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Elite Clinical Studies, LLC — Phoenix, Arizona, United States
- Advanced Investigative Medicine, Inc. — Hawthorne, California, United States
- Velocity Clinical Research - North Hollywood — North Hollywood, California, United States
- Chase Medical Research, LLC — Waterbury, Connecticut, United States
- Phoenix Medical Research, LLC — Miami, Florida, United States
- The Headache Clinic — Alexandria, Louisiana, United States
- Boston Clinical Trials — Boston, Massachusetts, United States
- Michigan Head Pain & Neurological Institute — Ann Arbor, Michigan, United States
- CVS HealthHub - East Brunswick — East Brunswick, New Jersey, United States
- CVS HealthHub - Lawrenceville — Lawrenceville, New Jersey, United States
- CVS HealthHUB - Runnemede — Runnemede, New Jersey, United States
- SPRI Clinical Trials, LLC — Brooklyn, New York, United States
- Velocity Clinical Research — Cincinnati, Ohio, United States
- OK Clinical Research, LLC — Edmond, Oklahoma, United States
- Clinical Research Philadelphia, LLC — Philadelphia, Pennsylvania, United States
- WR-ClinSearch, LLC — Chattanooga, Tennessee, United States
- VIP Trails — San Antonio, Texas, United States
- VIP Trials — San Antonio, Texas, United States
- Tidewater Integrated Medical Research — Virginia Beach, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.